Governance

Protocol for reviewing and approving funding requests outside the Commission's Competitive Grant and Local Government award cycles.

Official policy establishing the ethical standards, conflict-of-interest rules, and code of conduct that every Commission and committee member must follow.

The Commission's official catalog of approved, evidence-based opioid abatement and remediation strategies that grantees and projects must align with to qualify for settlement funding.

The 2021 compact between Delaware and its 10 eligible local governments that governs how national opioid settlement dollars are shared, allocated, and reported.

2025 Delaware law (signed Aug. 25, 2025) updating the Behavioral Health Consortium's charge and revising the Settlement Commission's chair structure, distribution authorities, and reporting requirements.

The National Opioids Settlement portal page listing Delaware's executed judgments and settlement agreements with Janssen, Teva, Allergan, Walgreens, and other defendants.

The Distributor Settlement Agreement schedule that lists the approved abatement uses Delaware's opioid settlement funds must support.

2021 Delaware law (signed Oct. 14, 2021) that created the Prescription Opioid Settlement Fund and the Prescription Opioid Distribution Commission to ensure settlement dollars are used to abate the opioid crisis.